Pharmax SA
Pharmax reported total assets of 586,278 € at the end of the 2025 financial year (annual accounts filed with the NBB on 24 Jun 2026).
The score of Pharmax shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +9 % Total assets +10 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharmax's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 76,733 € | ||||
| Equity | 457,161 € | ||||
| Cash | 361,161 € | ||||
| EBITDA | 108,171 € | ||||
| Total assets | 586,278 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 24 Jun 2026
- Year ended 31 Dec 2024filed on 17 Jul 2025
- Year ended 31 Dec 2023filed on 11 Jul 2024
- Year ended 31 Dec 2022filed on 23 Jun 2023
- Year ended 31 Dec 2021filed on 29 Jun 2022
Pharmax's financial analysis
- Solvency78.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmax
Pharmax's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0461.189.963
- VAT number
- BE0461189963
- Peppol
- Registered · 0208:0461189963 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 23 Jul 1997
- Registered office
- 4020 Liège
- Latest accounts
- 2025 · filed on 24 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmax (SA) has been based in Liège since 1997, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 76,733 € and equity of 457,161 €; its revenue is not published. Its solvency stands at 78.0%, above the median of its sector (41.5%).
Companies similar to Pharmax
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de la Cloche Retail sale of pharmaceutical products Amay · balance sheet 586,289 €
- Apotheek Hendrickx Retail sale of pharmaceutical products Hasselt · balance sheet 585,967 €
- Farmafleur Retail sale of pharmaceutical products Antwerp · balance sheet 542,076 €
- Sovitalis Retail sale of pharmaceutical products Herentals · balance sheet 587,254 €
- Beirnaert VG Retail sale of pharmaceutical products Destelbergen · balance sheet 584,335 €
- Geassocieerde Apotheek Merelbeke Retail sale of pharmaceutical products Merelbeke-Melle · balance sheet 588,299 €
- Maertens Pharma Associes Retail sale of pharmaceutical products Chimay · balance sheet 583,944 €
- Eeuwfeestapotheek Retail sale of pharmaceutical products Antwerp · balance sheet 583,835 €
Frequently asked questions about Pharmax
What is the revenue of Pharmax?
Pharmax files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmax?
In Belgium, the VAT number is the company number prefixed with BE: BE0461189963 for Pharmax, if the company is VAT-registered. Its company number (CBE) is 0461.189.963.
Where is the registered office of Pharmax?
According to the CBE register, the registered office of Pharmax is in 4020 Liège.
What is the equity of Pharmax?
At the close of the 2025 financial year, the equity of Pharmax amounts to 457,161 €, a solvency of 78.0% of total assets.
Who manages Pharmax?
The register lists 4 active mandates at Pharmax. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmax
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →